Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

813
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
813
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

304
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
304

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcome and Prognostication of Patients With Inflammatory and Immune Myopathies With and Without Chemotherapy in the United States.

Cureus·2025
Same author

Pearls and Oy-sters: Chronic Progressive External Ophthalmoplegia With Electrical Myotonia and Negative Initial Genetic Testing.

Neurology·2025
Same author

Clinicopathologic Features of Perineurial Breast Carcinoma Invasion into the Brachial Plexus (P8-11.004).

Neurology·2025
Same author

An Initial Diagnosis of the Myopathic Form of Carnitine Palmitoyl Transferase Type II Deficiency Made in a 65-year-Old.

Journal of clinical neuromuscular disease·2024
Same author

Curriculum Innovation: A Standardized Experiential Simulation Curriculum Equips Residents to Face the Challenges of Chief Year.

Neurology. Education·2024
Same author

Myopathy With Crescent of Nuclei: A Novel Histopathologic Finding in Desminopathy.

Journal of clinical neuromuscular disease·2024
Same journal

Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

Clinics in geriatric medicine·2026
Same journal

Preventive Cardiology for the Clinically Complex Older Adult.

Clinics in geriatric medicine·2026
Same journal

A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

Clinics in geriatric medicine·2026
Same journal

Secondary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Primary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

Clinics in geriatric medicine·2026
See all related articles

Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Innovative Use of nsPEF to Boost Peripheral Nerve Regeneration
09:24

Author Spotlight: Innovative Use of nsPEF to Boost Peripheral Nerve Regeneration

Published on: May 3, 2024

1.1K

Immunotherapy for Peripheral Nerve Disorders.

Andre Granger1, Elina Zakin1

  • 1Department of Neurology, New York University Grossman School of Medicine, 660 1st Avenue, New York, NY 10016, USA.

Clinics in Geriatric Medicine
|April 16, 2021
PubMed
Summary
This summary is machine-generated.

Choosing treatments for disabling inflammatory peripheral neuropathies in elderly patients requires careful consideration of immunotherapeutic options. This review highlights key factors for selecting appropriate therapies in the geriatric population.

Keywords:
CorticosteroidsImmunoglobulinMethylprednisolonePeripheral neuropathyPlasma exchangePrednisoneRituximab

More Related Videos

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing
07:13

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Published on: October 20, 2021

3.5K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.4K

Related Experiment Videos

Last Updated: Nov 9, 2025

Author Spotlight: Innovative Use of nsPEF to Boost Peripheral Nerve Regeneration
09:24

Author Spotlight: Innovative Use of nsPEF to Boost Peripheral Nerve Regeneration

Published on: May 3, 2024

1.1K
Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing
07:13

Implantation and Control of Wireless, Battery-free Systems for Peripheral Nerve Interfacing

Published on: October 20, 2021

3.5K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.4K

Area of Science:

  • Neurology
  • Immunology
  • Geriatrics

Background:

  • Inflammatory peripheral neuropathies are debilitating conditions.
  • Treatment selection is complex, particularly for elderly patients.
  • Geriatric patients present unique challenges for managing these neuropathies.

Purpose of the Study:

  • To review immunotherapeutic options for peripheral nerve diseases.
  • To discuss critical considerations for treatment selection in the geriatric population.

Main Methods:

  • Literature review of immunotherapies for peripheral neuropathies.
  • Analysis of factors influencing treatment choices in elderly individuals.

Main Results:

  • Various immunotherapeutic agents are available for peripheral neuropathies.
  • Age-related physiological changes and comorbidities impact treatment efficacy and safety.
  • Personalized treatment strategies are essential for optimal outcomes.

Conclusions:

  • Effective management of inflammatory peripheral neuropathies in the elderly necessitates a tailored approach.
  • Careful consideration of immunotherapeutic options and patient-specific factors is crucial.
  • Optimizing treatment in geriatric patients can improve quality of life and reduce disability.